Correlation Between Bio Gene and Medical Developments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Medical Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Medical Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Medical Developments International, you can compare the effects of market volatilities on Bio Gene and Medical Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Medical Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Medical Developments.

Diversification Opportunities for Bio Gene and Medical Developments

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bio and Medical is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Medical Developments Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Developments and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Medical Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Developments has no effect on the direction of Bio Gene i.e., Bio Gene and Medical Developments go up and down completely randomly.

Pair Corralation between Bio Gene and Medical Developments

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Medical Developments. In addition to that, Bio Gene is 1.35 times more volatile than Medical Developments International. It trades about 0.0 of its total potential returns per unit of risk. Medical Developments International is currently generating about 0.15 per unit of volatility. If you would invest  47.00  in Medical Developments International on November 6, 2024 and sell it today you would earn a total of  33.00  from holding Medical Developments International or generate 70.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  Medical Developments Internati

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Medical Developments 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Medical Developments International are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Medical Developments unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bio Gene and Medical Developments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and Medical Developments

The main advantage of trading using opposite Bio Gene and Medical Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Medical Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will offset losses from the drop in Medical Developments' long position.
The idea behind Bio Gene Technology and Medical Developments International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets